Heron Bay Capital Management Biogen Inc. Transaction History

Heron Bay Capital Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $615,607 - $775,632	-3,177 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $308,785 - $396,834	-1,379 Reduced 30.27%	3,177 $762,000
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $19,526 - $25,464	69 Added 1.54%	4,556 $1.29 Million
Q2 2021 Aug 10, 2021	SELL	$259.0 - $414.71 $716,135 - $1.15 Million	-2,765 Reduced 38.13%	4,487 $1.55 Million
Q1 2021 May 14, 2021	BUY	$242.95 - $284.63 $253,153 - $296,584	1,042 Added 16.78%	7,252 $2.03 Million

Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $1.47 Million - $2.21 Million	6,210 New	6,210 $1.52 Million

1,046

126M

1.37M

1.35M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $33.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Heron Bay Capital Management, based on Form 13F filings with the SEC.

Stay updated on Heron Bay Capital Management with notifications on news.